-- Bio Light Headed for Biggest Gain in Month on Glaucoma Permit
-- B y   S h o s h a n n a   S o l o m o n
-- 2012-03-22T09:56:42Z
-- http://www.bloomberg.com/news/2012-03-22/bio-light-headed-for-biggest-gain-in-month-on-glaucoma-permit.html
  Bio Light Israeli Life Sciences
Investments Ltd. (BOLT)  headed for its biggest gain in more than a
month after the developer of drugs and medical technology said a
unit got approval to market a glaucoma surgery device.  The  shares  advanced 2.1 percent, headed for the biggest
gain since Feb. 21, to 0.197 shekel at 11 a.m. in  Tel Aviv ,
giving the Ramat Gan, Israel-based company a market value of 35
million shekels ($9.3 million).  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  